These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18548234)

  • 41. The effects of nicotine on cognition are dependent on baseline performance.
    Niemegeers P; Dumont GJ; Quisenaerts C; Morrens M; Boonzaier J; Fransen E; de Bruijn ER; Hulstijn W; Sabbe BG
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1015-23. PubMed ID: 24766971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.
    Allen MH; Debanné M; Lazignac C; Adam E; Dickinson LM; Damsa C
    Am J Psychiatry; 2011 Apr; 168(4):395-9. PubMed ID: 21245085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.
    Grundey J; Amu R; Ambrus GG; Batsikadze G; Paulus W; Nitsche MA
    Psychopharmacology (Berl); 2015 Jul; 232(14):2491-501. PubMed ID: 25721074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nicotine-induced activation of caudate and anterior cingulate cortex in response to errors in schizophrenia.
    Moran LV; Stoeckel LE; Wang K; Caine CE; Villafuerte R; Calderon V; Baker JT; Ongur D; Janes AC; Evins AE; Pizzagalli DA
    Psychopharmacology (Berl); 2018 Mar; 235(3):789-802. PubMed ID: 29181816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
    Meltzer HY; McGurk SR
    Schizophr Bull; 1999; 25(2):233-55. PubMed ID: 10416729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transdermal nicotine effects on attention.
    Levin ED; Conners CK; Silva D; Hinton SC; Meck WH; March J; Rose JE
    Psychopharmacology (Berl); 1998 Nov; 140(2):135-41. PubMed ID: 9860103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of anticholinergic medication on memory in schizophrenia.
    Strauss ME; Reynolds KS; Jayaram G; Tune LE
    Schizophr Res; 1990; 3(2):127-9. PubMed ID: 1980611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
    Lemay S; Chouinard S; Blanchet P; Masson H; Soland V; Beuter A; Bédard MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):31-9. PubMed ID: 14687854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.
    Hahn B; Harvey AN; Concheiro-Guisan M; Huestis MA; Holcomb HH; Gold JM
    Biol Psychiatry; 2013 Sep; 74(6):436-43. PubMed ID: 23660272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nicotine patches improve mood and response speed in a lexical decision task.
    Gentry MV; Hammersley JJ; Hale CR; Nuwer PK; Meliska CJ
    Addict Behav; 2000; 25(4):549-57. PubMed ID: 10972446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the nicotine patch on performance during the first week of smoking cessation.
    Cook MR; Gerkovich MM; Graham C; Hoffman SJ; Peterson RC
    Nicotine Tob Res; 2003 Apr; 5(2):169-80. PubMed ID: 12745489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recollection and familiarity in negative schizophrenia.
    Thoma P; Zoppelt D; Wiebel B; Daum I
    Neuropsychologia; 2006; 44(3):430-5. PubMed ID: 15993449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Memory deficits and anticholinergic levels in chronic schizophrenia.
    Perlick D; Stastny P; Katz I; Mayer M; Mattis S
    Am J Psychiatry; 1986 Feb; 143(2):230-2. PubMed ID: 3946662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deficient relational binding processes in adolescents with psychosis: evidence from impaired memory for source and temporal context.
    Doré MC; Caza N; Gingras N; Rouleau N
    Cogn Neuropsychiatry; 2007 Nov; 12(6):511-36. PubMed ID: 17978937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
    Potter AS; Newhouse PA
    Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transdermal nicotine modulates strategy-based attentional semantic processing in non-smokers.
    Holmes AD; Chenery HJ; Copland DA
    Int J Neuropsychopharmacol; 2008 May; 11(3):389-99. PubMed ID: 18047753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients.
    Serper MR; Bergman A; Copersino ML; Chou JC; Richarme D; Cancro R
    Psychiatry Res; 2000 Feb; 93(1):21-32. PubMed ID: 10699225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.